NDC product
Childrens Allergy
NDC 51316-260 · CVS PHARMACY, INC
Key facts
| Product NDC | 51316-260 |
|---|---|
| Proprietary name | Childrens Allergy |
| Nonproprietary name | Fexofenadine HCl |
| Substances | FEXOFENADINE HYDROCHLORIDE |
| Dosage form | SUSPENSION |
| Route | ORAL |
| Labeler | CVS PHARMACY, INC |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA203330 |
| Pharmacologic classes | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
| Marketing start | Oct 15, 2023 |
| Marketing end | Dec 28, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory